News-Medical.Net on MSN

New consortium aims to fast-track breakthroughs against follicular lymphoma

Follicular lymphoma (FL) is the second most frequent subtype of non-Hodgkin lymphoma, a cancer of the immune system. Although ...

Merck Drug Gets Fast-Track Designation from FDA for Alzheimer's Treatment

Merck's MK-2214 drug received fast-track designation from the Food and Drug Administration for treatment of Alzheimer's disease. The Rahway, N.J., company said Monday that it would present data this ...
InvestorsHub on MSN

Incannex Healthcare leaps after FDA awards Fast Track designation for OSA therapy

Incannex Healthcare Inc. (NASDAQ:IXHL) surged 19.2% in premarket trading on Wednesday after revealing that the U.S. Food and Drug Administration has granted Fast Track status to IHL-42X, its ...

Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia

Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 to address a broad ...

Incannex Gets FDA Fast Track Designation for Sleep Apnea Treatment

Incannex Healthcare received fast track designation from the Food and Drug Administration for its IHL-42X treatment of obstructive sleep apnea.
Becker's Hospital Review

Merck Alzheimer’s drug granted FDA fast-track designation

Merck’s investigational antibody MK-2214 has received fast-track designation from the FDA for the treatment of Alzheimer’s disease. MK-2214 targets phosphorylated serine 413 tau (pS413), a marker of ...